000 00605nam a2200109Ia 4500
008 230817s9999 xx 000 0 und d
100 _aLorena Incorvaia et al
245 0 _aProgrammed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org/sites/default/files/2023-08/programmed_death_ligand_1_pd-l1_as_a_predictive_biomarker_for_pembrolizumab_therapy_in_patients_with_advanced_non-small-cell_lung_cancer_nsclc.pdf
942 _cEBK
999 _c37185
_d37185